Physician profile
Benjamin Aaron Morrison
NPI 1073977781
$11,142.61
in general payments reported to CMS, 2019-2025
53 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $818 · 2021: $1,726 · 2022: $2,279 · 2023: $1,972 · 2024: $2,396 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,044.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,792.20 | 2020-2025 | |
| Novo Nordisk INC | $1,623.37 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,275.29 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $870.00 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $818.09 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $675.06 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $671.67 | 2019-2025 | |
| Inspire Medical Systems, INC. | $325.20 | 2023-2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $268.23 | 2022 | |
| Shield Therapeutics INC | $213.49 | 2022-2025 | Accrufer |
| Biohaven Pharmaceuticals, INC. | $194.15 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $177.97 | 2021-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $163.98 | 2020-2023 | Trintellix |
| Hikma Pharmaceuticals USA | $151.30 | 2021-2024 | Kloxxado, Ryaltris, Mitigare |
| Dexcom, INC. | $150.26 | 2022-2025 | Dexcom G6 Transmitter |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $140.97 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.98 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $134.30 | 2019-2025 | Lagevrio, Gardasil 9, Capvaxive |
| Supernus Pharmaceuticals, INC. | $100.02 | 2024-2025 | Qelbree |
| Corium, LLC | $90.68 | 2021-2023 | Azstarys |
| Boston Scientific Corporation | $75.60 | 2024 | |
| Abbott Laboratories | $74.50 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Ibsa Pharma INC. | $73.03 | 2020-2023 | Tirosint, Licart |
| Exact Sciences Corporation | $63.75 | 2023-2024 | Cologuard Collection Kit |
| Eyevance Pharmaceuticals LLC | $63.15 | 2021 | |
| Tris Pharma INC | $53.93 | 2023-2025 | Dyanavel Xr |
| Endo Pharmaceuticals INC. | $51.65 | 2020 | |
| Sanofi Pasteur INC. | $50.79 | 2022-2025 | |
| Genentech USA, INC. | $46.79 | 2020 | |
| Amneal Pharmaceuticals LLC | $46.67 | 2021-2024 | Unithroid |
| Antares Pharma, INC. | $38.54 | 2020-2025 | Xyosted |
| Horizon Therapeutics Plc | $37.61 | 2020-2022 | |
| Astellas Pharma US INC | $36.94 | 2024-2025 | Veozah |
| Bausch Health US, LLC | $36.47 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $35.18 | 2022 | |
| Neos Therapeutics, LP | $35.01 | 2020-2024 | Adzenys Xr-Odt |
| Acella Pharmaceuticals, LLC | $34.55 | 2024 | NP Thyroid 60 |
| Daiichi Sankyo INC. | $32.70 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $29.53 | 2023 | Quviviq |
| Nevro Corp. | $27.54 | 2023 | Senza |
| Medtronic, INC. | $23.84 | 2025 | Interstim |
| Mayne Pharma Commercial LLC | $21.63 | 2025 | |
| Noven Therapeutics, LLC | $20.62 | 2025 | Xelstrym |
| Aytu Biopharma, INC. | $18.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.39 | 2025 | |
| Esperion Therapeutics, INC. | $18.30 | 2025 | Nexletol |
| Arbor Pharmaceuticals, INC. | $17.96 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.18 | 2025 | Nuzyra, Xhance |
| Eisai INC. | $16.05 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.83 | 2023 | Xarelto |
| Adlon Therapeutics L.P. | $13.81 | 2020 | |
| Agile Therapeutics, INC. | $13.41 | 2023 | Twirla |
| Teva Pharmaceuticals USA, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.